Abstract 12698: Alert-Driven versus Scheduled Remote Monitoring of Implantable Cardiac Defibrillators: An Economic Analysis From the Trust Randomized Trial

Derek S. Chew, Jonathan P. Piccini,Flora Au, Camille Frazier‐Mills, Justin Michalski,Niraj Varma

Circulation(2022)

引用 0|浏览0
暂无评分
摘要
Introduction: Current implementation of remote patient monitoring (RPM) for implantable cardioverter defibrillators (ICDs) involves a hybrid of remote assessment and in-person evaluation (IPE) every 3 months. Alert-driven RPM or fully virtual care without routine visits may reduce non-actionable patient evaluation, increased clinic workload and inefficient resource allocation. Objective: To conduct a cost-consequence analysis to compare three patient management strategies following ICD implantation: (a) IPE only, (b) RPM-conventional (hybrid of IPE and RPM), and (c) RPM-alert (alert-based ICD follow up). Methods: We constructed a decision-analytic Markov model to estimate the costs and benefits of three strategies of patient management following ICD implantation over a two-year time horizon from the perspective of the US healthcare system. Aggregate and patient-level data from the TRUST (Lumos-T Safely RedUceS RouTine Office Device Follow-up) clinical trial informed clinical effectiveness model inputs. TRUST randomized 1339 patients 2:1 to conventional RPM or IPE alone, and found that RPM was safe and reduced the number of non-actionable encounters. Cost data was obtained from the published literature. The primary outcome was incremental cost. Results: The mean cumulative costs per patient were $12,688 in the IPE group, $12,001 in the RPM-conventional group, and $11,011 in the RPM-alert group. Compared to the IPE group, both the RPM-conventional and RPM-alert groups were associated with lower incremental costs of -$687 (95% confidence interval (CI)-$2,138 to +$638) and -$1,677 (95% CI -$3,134 to -$304), respectively. Of the three groups, the RPM-alert strategy was the most cost-effective strategy with an estimated cost-savings in 99% of simulations. Conclusions: Alert-driven RPM was economically attractive and, if patient outcomes and safety are comparable to conventional RPM, may be the preferred strategy of patient follow up.
更多
查看译文
关键词
implantable cardiac defibrillators,remote monitoring,trust randomized trial,alert-driven
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要